Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia
Udomsak Bunworasate(Chulalongkorn University), Maria R. Baer(University of Maryland, Baltimore), Hans Minderman(Roswell Park Comprehensive Cancer Center), Sheila N.J. Sait(Roswell Park Comprehensive Cancer Center), Maurice Barcos(Roswell Park Comprehensive Cancer Center), Kieran L. O’Loughlin(Roswell Park Comprehensive Cancer Center), Carleton C. Stewart(University of Maryland, Baltimore), Hilal Arnouk(Roswell Park Comprehensive Cancer Center)
Cited by 35
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795